Preoperative glucagon-like peptide-1 receptor agonist use is not associated with short-term postoperative aspiration pneumonia.
GLP-1 RA use was linked to lower risks for myelodysplastic syndromes and myeloproliferative neoplasms compared with metformin. HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like ...
21h
SurvivorNet on MSNCan GLP-1 Drugs for Weight Loss Lower Cancer Risk? What Patients Need to Know About Obesity and CancerBecause obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...
Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.
3h
Daily Maverick on MSNNew chronic kidney disease treatments show promise, but are expensive and inaccessibleWhile the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...
Robard Corporation, a trusted leader in scientifically designed nutrition products for the medical weight management community since 1976, today announced the reformulation of Biocare — its ...
Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
1hon MSN
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results